Xiangxue Pharmaceutical (300147) — Cash Flow Reinvestment Rate
Xiangxue Pharmaceutical (300147) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥5.74 Million (capex CN¥5.74 Million ) from operating cash flow of CN¥75.64 Million. Explore how much does Xiangxue Pharmaceutical reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiangxue Pharmaceutical Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Xiangxue Pharmaceutical across 19 annual periods. Also explore total assets of Xiangxue Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xiangxue Pharmaceutical (2007–2025)
Year-by-year capital reinvestment analysis for Xiangxue Pharmaceutical. For live market cap and broader valuation context, see 300147 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥25.47 Million | CN¥139.63 Million | CN¥21.51 Million | ▼ -94.4% |
| 2024 | 3.24x | CN¥58.95 Million | CN¥18.17 Million | CN¥35.24 Million | ▲ +678.9% |
| 2023 | 0.42x | CN¥109.69 Million | CN¥263.44 Million | CN¥56.03 Million | ▼ -77.7% |
| 2022 | 1.87x | CN¥425.18 Million | CN¥227.38 Million | CN¥367.27 Million | ▼ -21.2% |
| 2021 | 2.37x | CN¥611.43 Million | CN¥257.56 Million | CN¥562.74 Million | ▼ -15.2% |
| 2020 | 2.80x | CN¥719.65 Million | CN¥257.18 Million | CN¥707.42 Million | ▼ -77.3% |
| 2019 | 12.34x | CN¥1.02 Billion | CN¥83.02 Million | CN¥661.09 Million | ▲ +82.4% |
| 2018 | 6.76x | CN¥617.05 Million | CN¥91.24 Million | CN¥495.46 Million | ▼ -19.3% |
| 2017 | 8.38x | CN¥917.76 Million | CN¥109.53 Million | CN¥777.87 Million | ▼ -23.6% |
| 2016 | 10.97x | CN¥2.18 Billion | CN¥198.48 Million | CN¥1.97 Billion | ▲ +183.3% |
| 2015 | 3.87x | CN¥618.83 Million | CN¥159.89 Million | CN¥276.95 Million | ▲ +162.8% |
| 2014 | 1.47x | CN¥243.85 Million | CN¥165.58 Million | CN¥243.85 Million | ▲ +51.8% |
| 2013 | 0.97x | CN¥318.55 Million | CN¥328.37 Million | CN¥318.55 Million | ▼ -72.4% |
| 2012 | 3.52x | CN¥418.12 Million | CN¥118.91 Million | CN¥418.12 Million | ▼ -55.0% |
| 2011 | 7.81x | CN¥230.69 Million | CN¥29.55 Million | CN¥230.69 Million | ▲ +524.1% |
| 2010 | 1.25x | CN¥56.87 Million | CN¥45.47 Million | CN¥56.87 Million | ▲ +9.3% |
| 2009 | 1.14x | CN¥52.86 Million | CN¥46.19 Million | CN¥52.86 Million | ▼ -53.7% |
| 2008 | 2.47x | CN¥137.71 Million | CN¥55.72 Million | CN¥137.71 Million | ▲ +135.7% |
| 2007 | 1.05x | CN¥144.73 Million | CN¥138.02 Million | CN¥144.73 Million | — |